18.21
1.40 (8.33%)
1.40 (8.33%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aerie Pharmaceuticals Inc | AERI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.40 | 8.33% | 18.21 | 16:02:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.90 | 16.87 | 19.09 | 18.27 | 16.81 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 17.51 | 18.41 | 0.90 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16,340 | 2,504,138 | $ 18.10 | $ 45,326,303 | 596,702 | 9.01 - 23.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:51 | formt | 844 | $ 18.21 | USD |
Aerie Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 852.50M | 46.81M | 34.03M | $ 69.89M | $ - | -4.39 | -4.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aerie Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AERI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.22 | 19.09 | 14.02 | 15.96 | 1,212,568 | 3.99 | 28.06% |
| 1 Month | 14.50 | 19.09 | 12.71 | 14.73 | 601,517 | 3.71 | 25.59% |
| 3 Months | 10.66 | 19.09 | 10.275 | 13.22 | 600,172 | 7.55 | 70.83% |
| 6 Months | 13.12 | 19.09 | 9.01 | 12.04 | 693,616 | 5.09 | 38.8% |
| 1 Year | 21.09 | 23.39 | 9.01 | 13.97 | 800,777 | -2.88 | -13.66% |
| 3 Years | 56.00 | 74.75 | 9.01 | 27.72 | 714,698 | -37.79 | -67.48% |
| 5 Years | 19.03 | 74.75 | 9.01 | 31.48 | 649,052 | -0.82 | -4.31% |
Aerie Pharmaceuticals Description
| Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America. |
